Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical approaches to pharmacodynamic modeling: motivations, methods, and misperceptions

R Mick1, M J Ratain

  • 1Department of Medicine, University of Chicago, Pritzker School of Medicine, IL 60637.

Cancer Chemotherapy and Pharmacology
|January 1, 1993
PubMed
Summary

Pharmacodynamic modeling addresses patient variability in drug effects by analyzing pharmacokinetic and pharmacodynamic factors. Statistical methods help individualize drug dosing for better treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

Clinical pharmacology and therapeutics·2017
Same author

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.

Clinical pharmacology and therapeutics·2017
Same author

Food Effect Studies for Oncology Drug Products.

Clinical pharmacology and therapeutics·2017
Same author

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.

Clinical pharmacology and therapeutics·2016
Same author

ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia.

The pharmacogenomics journal·2016

Area of Science:

  • Pharmacology
  • Biostatistics
  • Oncology

Background:

  • Patient variability in drug response necessitates pharmacodynamic investigations.
  • Pharmacokinetic and pharmacodynamic factors contribute to interpatient variability in treatment effects.
  • Residual variability after accounting for drug exposure highlights the need for advanced statistical modeling.

Purpose of the Study:

  • To outline fundamental statistical aspects of pharmacodynamic modeling.
  • To emphasize understanding effect measures and explanatory variables.
  • To guide the construction and assessment of pharmacodynamic models.

Main Methods:

  • Discussed statistical model assumptions and residual analysis for assumption verification.
  • Described transformations and alternative regression methods for assumption violations.

Related Experiment Videos

  • Presented sequential selection procedures for multivariate model construction.

    • Main Results:

    • Highlighted the importance of assessing model performance, focusing on bias and precision.
    • Emphasized understanding variable properties (scale, distribution, relationships).
    • Noted the variability in content and format of pharmacodynamic analyses in oncology literature.

    Conclusions:

    • Pharmacodynamic analyses are common in oncology but their appropriateness and performance are often difficult to judge.
    • Understanding statistical properties and model assumptions is crucial for robust pharmacodynamic modeling.
    • A checklist format is suggested for structuring pharmacodynamic analysis presentations to improve clarity and reproducibility.